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Abstract
Objective: To prove the success of supportive psychotherapy that
was provided as a distress therapy on advanced cervical cancer.
Knowing the prevalence of distress type of depression in patient
with epithelial cervical cancer, proving the benefits of psychothe-
rapy supportive for distress can decreasing cortisol level in cervical
cancer patient, can assess distress thermometer score, HAM-D17
score and scoring incident predictors of distress with depression
type.
Methods: There were 32 subjects from 71 advanced cervical cancer
patients had mild-moderate depression. Then randomization
blocking was performed to determine a subject who entered the
treatment group (n = 16) who got supportive psychotherapy or
control group who got common psychotherapy (n = 16). All of
participants assessed the distress level with cortisol value, distress
thermometer score, and HAM-D17 score before and after they got
supportive psychotherapy.
Results: After the intervention of psychotherapy in the treatment
group decreased HAM-D17 score, the average decline 7.53 (SB 3.34).
The mean decreasing in the control group was 3.98 (SB 2.85). There
is a significant difference in mean reduction in HAM-D17 scores on
treatment and control groups with p = 0.003 (p <0.005). There was
decreasing blood cortisol level in the treatment group amounted to
39.43, while the control group there was a drop of 1.59. The reduc-
tion of cortisol level in the treatment group and the control has a p-
value 0.302. After got supportive psychotherapy, found a decreasing
the average value of the thermometer distress in the treatment
group 3.02 and the control group 2.51, with a p value more than
0.492.
Conclusion: There were 45% of cervical cancer patients in the clinic
experiencing distress disorder with depressive type. The blood
cortisol level could be decreased by giving supportive psychothe-
rapy with a mean decrease of 39.43 nmol/l. There was a significant
reduction in the level of depression (HAM-D17 score) of 7.53 points
and distress thermometer impairment by 3 points after given
supportive psychotherapy. Obtained scoring predictors for the
occurrence of distress type of depression in patients with advanced
cervical cancer with a sensitivity of 46.15% and a specificity of
89.47%.
[Indones J Obstet Gynecol 2018; 6-3: 179-187]
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Abstrak
Tujuan: Untuk membuktikan keberhasilan psikoterapi suportif yang
diberikan sebagai terapi distress pada kanker serviks stadium lanjut.Mengetahui prevalensi distress tipe depresi pada pasien kanker serviks
epitelial, manfaat psikoterapi suportif terhadap distress pasien kanker
serviks stadium lanjut dalam menurunkan kadar kortisol, nilai ther-mometer distress, nilai HAM-D17 dan scoring predictor terjadinya dis-
tress tipe depresi pada pasien kanker serviks stadium lanjut.
Metode: Didapatkan 32 subjek penelitian dari 71 pasien kanker
serviks stadium lanjut yang memenuhi kriteria inklusi (45%) yangmengalami distress sedang-berat tipe depresi ringan-sedang dan
selanjutnya dilakukan randomisasi blok untuk menentukan subjek
yang masuk kelompok perlakuan (n=16) dan kontrol (n=16). Sam-pel penelitian akan diberi penerangan terlebih dahulu dan bila
sudah dapat dimengerti dan dipahami maka pasien diminta untuk
menandatangani lembar persetujuan. Setelah pasien menyetujuiuntuk ikut serta dalam penelitian, selanjutnya pasien akan dinilai
tingkat distress dengan kadar kortisol, nilai thermometer distress,dan nilai HAM-D17 sebelum dan sesudah psikoterapi suportif.
Hasil: Setelah dilakukan intervensi psikoterapi pada kelompok per-lakuan terjadi penurunan skor HAM-D17, rerata penurunannya 7,53
(SB 3,34). Rerata penurunan pada kelompok kontrol 3,98 (SB 2,85).
Terdapat perbedaan yang bermakna penurunan rerata skor HAM-D17 kelompok perlakuan dan kontrol dengan nilai p=0,003 (p<0,005).
Terdapat penurunan kadar kortisol darah pada kelompok perlakuansebesar 39,43 sedangkan pada kelompok kontrol terdapat penurunan
sebesar 1,59. Penurunan kadar kortisol pada kelompok perlakuan dan
kontrol ini memiliki nilai p 0,302. Setelah diberikan psikoterapi supor-tif, didapatkan penurunan rerata nilai thermometer distress pada
kelompok perlakuan sebesar 3,02 dan pada kelompok kontrol sebesar
2,51 dengan nilai p lebih dari 0,492.
Kesimpulan: Terdapat 45% pasien kanker serviks di poliklinik yangmengalami gangguan distress tipe depresi yang bermakna, penu-
runan kadar kortisol darah sesudah diberikan psikoterapi suportif
dengan rerata penurunan sebesar 39,43 nmol/l pada penderitakanker serviks yang mengalami distress tipe depresi, penurunan ber-
makna tingkat depresi (skor HAM-D17) sebesar 7,53 poin sesudah
diberikan psikoterapi suportif pada penderita kanker serviks yangmengalami distress tipe depresi, penurunan nilai thermometer distress
sebesar 3 poin sesudah diberikan psikoterapi suportif pada penderitakanker serviks yang mengalami distress tipe depresi dan didapatkan
skoring prediktor terjadinya distress tipe depresi pada pasien kanker
serviks stadium lanjut dengan sensitivitas 46,15% dan spesifisitas89,47%.
[Maj Obstet Ginekol Indones 2018; 6-3: 179-187]
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INTRODUCTION
The majority of cancer patients experience distress
condition caused by the cancer itself and treatment
they are going through. Research shows 20-40% of
cancer patients experience meaningful distress.1
The prevalence of distress in gynecological cancer
patients is around 30%. Research on patients being
treated at the hospital showed a high incidence of
either depression (20-45%) or delirium (increased
from 15% to 75% due to the increasing severity of
the disease).1
The most gynecological cancer in Indonesia is
cervical cancer. Problems faced by patients ranging
from cervical cancer-related disease such as vagi-
nal bleeding, pelvic pain, smelly vaginal-discharge
until sexual relationship problems which probably
felt until died. All of these problems will lead to a
meaningful distress of her life. Definition of distress
in cancer patients is an uncomfortable multifacto-
rial emotional experience that either comes from
psychological problems or social/spiritual/religious
problems that could interfere with their ability to
face cancer, physical symptoms and the cancer
therapy itself effectively (NCCN).1,2 The use of the
word distress selected by the NCCN aims to elimi-
nate or reduce the stigma attached to such words
like psychiatric, psychological, or emotional.1,2
Screening and identification of psychological
distress in the early presence of distress would
make the management become more effective and
therefore could improve the quality of cancer care
management and improve the survival.1,2 NCCN
(The National Comprehensive Cancer Network)
recommends distress screening to all cancer
patients, psychosocial therapy integration and the
development of a treatment plan with referral to
the psychosocial management center if needed into
a routine cancer therapy in all cancer patients.1
NCCN recommends the use of distress ther-
mometer to identify the presence of distress.
Distress thermometer is a tool similar to the initial
screening scale of measurement for pain: a value
of 0 (no distress) up to a value of 10 (the most
severe distress). In this study, the results of
measurements of the distress thermometer are
grouped into three groups namely the values 1-3
as a group of mild distress, 4-6 as a moderate
distress group and 7-10 as a severe distress group.
The current use of the distress thermometer has
been used widely in integration of psychiatric
counseling and psychosocial therapies into a better
comprehensive service or hospitality for cancer
patients.1,3
In addition to assessing distress condition, there
is laboratory examination of cortisol, which is
often known as the stress hormone which is the
organism’s response to stress and anxiety/restless-
ness.4 Cortisol is a hormone that is released
through the glucocorticoid mechanism along the
Hypothalamus-Pituitary-Adrenal (HPA) axis as a
response to inflammation (Rhen and Cidlowski,
2005), stress and other stimulus (Chrousos and
Gold, 2005) which roled as a regulator in important
metabolic functions.5 Dallman, Tsigos, Chrousus, et
al conclude cortisol level influenced by circadian
cycles (diurnal rhythm) with the highest level in
the morning and continues to diminish throughout
the afternoon and evening and reached a nadir
when the middle of the night.4,5 As a response of
the body to face with the stress then the suprachi-
asmatic neurons in the hypothalamus secretes
Corticotrophin-Releasing Hormone (CRH), which
will further stimulate the secretion of Adreno-
Corticotropic Hormone (ACTH) released from the
pituitary which will eventually stimulate the adre-
nal cortex to release cortisol. Then negative feed-
back mechanism would happen by which cortisol
would suppress the production of CRH and ACTH
in hypothalamus and hypophysis. But in certain
circumstances such as chronic inflammatory and
cancer, found negative feedback is not well res-
ponse so that diurnal cortisol rhythm disorder
would happen.6
Zhang et al. declared glucocorticoid would
stimulate gene expression of anti-apoptosis and act
as antagonistic toward cytotoxic capability against
epithelial cancer cells (solid tumors).7 Volde and
Conzen found cortisol/glucocorticoids would in-
hibit the process of apoptosis in breast, cervical
and ovarian cancer cells.6 In vitro model of ovarian
cancer, cortisol can cause effects obtained by
catecholamine; ability of tumor invasion (Nakane
et al, 1990; Sood et al 2006), improved regulatory
factors such as VEGF angiogenic-pro (Lutgendorf
et al., 2003) and the expression of matrix metallo-
proteinase (Lutgendorf et al, 2008).8,9 Abercrombie
et al. discovered that breast cancer patients with
more advanced stages would have higher average
cortisol level than patients with earlier stage and
Sephton et al. also discovered the existence of the
curve cortisol more ramps.8
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A research in the relationship of diurnal cortisol
level and survival in epithelial ovarian cancer
patients revealed that an increasing one standard
deviation of the cortisol level is associated with an
increased risk of death of 46% and at group that
have higher level of cortisol have a survival average
3.3 years whereas in the group who have lower
cortisol level have a survival average of 7.3 years.
And that’s the important rationale of why the
psychotherapy becomes an important basis -
because it attempts to decrease the cortisol level.
Stommel et al. reported cancer patients with a
history of depression would have the risk of death
2, six times in the first 19 months after initial
diagnosis of depression found. Faller et al.
conducted a study on 103 cancer patients,
demonstrated the state of depression that also
related to decreased survival time. With regard to
the potential direct impact on survival, the
depression that arises would make a decrease in
compliance against therapy, extended hospital care
time, reduced the quality of life and ability to take
care of themselves.10
While the definition of depression itself is a
mood disorder characterized by the presence of
abnormality in the mood, impaired psychomotor,
impaired cognitive function and biorhythms
disorders. Then to make diagnosis of depression
using the diagnostic criteria for major depressive
disorder based on DSM-V (Diagnostic and Statis-
tical Manual of Mental Disorders Fifth edition) as
a censorship.10 RSCM used screening diagnosis of
depression according to SCID (Structured Clinical
Interview for DSM)-I Indonesian version January
2000 v1.01. And proceed using the Hamilton
Psychiatric Rating Scale for Depression (HAM-D17)
as a tool to ensure the diagnosis of depression,
assessing the success of therapy and categorizing
depression scale based on score/total value calcu-
lated. HAM-D17 scale is a scale often used in clini-
cal research as a golden standard.
Other scales than HAM-D17 are Montgomery-
Asberg Depression Rating Scale (MADRS), the Beck
Depression Inventory (BDI), the Zunf Self-Depres-
sion Rating Scale, the Wechsler Depression Rating
Scale, the Raskin Depression Rating Scale, and
others.
METHOD
This study was a clinical trials/randomized experi-
mentsubtle parallel design. The intervention group
was invasive cervical cancer epithelial type ad-
vanced stage (IIB - IVB) who have experienced dis-
tress level of moderate to severe depression-type
with mild-moderate who get special Psychothe-
rapy/supportive Psychotherapy (Department of
Psychiatry). The comparison group is invasive cer-
vical cancer epithelial type advanced stage (IIB -
IVB) who have experienced distress level of
moderate to severe depression-type with mild-
moderate who get Psychotherapy (Gynecologic
Oncology Division). Determination of the distress
level based distress thermometer which is deter-
mined by patients themselves with the explanation
by Obstetrics and Gynecology doctor. In this study
the results of measurements of the distress ther-
mometer are grouped into three groups namely
the values 1-3 as a group of mild distress, the
values 4-6 as distress groups and the values 7-10
as heavy distress group. In addition to the distress
thermometer also added a questionnaire in the
form of a list of 35 problems to help patients
identify their problem quickly into five different
categories: practical daily life issues, family
problems, emotional problems, spiritual/religious
problems and physical problems. The assessment
and determination of the type of depression and
distress degree of depression were done by a
psychiatry doctor. The diagnosis of depression
screening used by RSCM is SCID (Structured
Clinical Interview for DSM)-I version the language
Indonesia January 2000 v1.01. Then proceed with
using the Hamilton Psychiatric Rating Scale for
Depression (HAM-D17) as a tool to ensure the
diagnosis of depression, assessing the success of
therapy and categorize the light weight depression
based on score/total value that calculated. Cate-
gory of the depression degree based on HAM-D17
is normal when the value 0-7; mild depression
when the value 8-13; depression are when the
value of 14-18; severe depression when the value
of 19-22. Inspection and measurement of patient’s
blood cortisol level conducted by the Biochemistry
Laboratory Medical Faculty, University of Indo-
nesia in Jakarta. Then the General Psychotherapy
conducted in Gynecologic Oncology Division Clinic
and Special Psychotherapy conducted in the Adult
Psychiatry Polyclinic Department of RSUPN Dr.
Cipto Mangunkusumo. Determination of the
sample is randomized in sealed envelope.
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The inclusion criterion is cervical epithelial
cancer patients with advanced stage (Stage IIB -
IVB) who are willing to participate in as a subject
of research. Whereas the exclusion criterions are
neuroendocrine type of cervical cancer, cervical
cancer in pregnancy and cervical cancer patients
who experience severe depression type of distress.
Some of the variables examined in this research
include independent variables such as; age, educa-
tion, marital status, advanced stage of cervical
cancer, religion, occupation, parity and ethnicity
and dependent variables such as; cortisol level,
distress thermometer score, and HAM-D17 score.
The involvement of these variables can be seen
from research concept framework chart below:
RESULTS AND DISCUSSION
Purposive sampling method had been conducted
from 14th of June until 27th of October 2016 at
RSCM Gynecologic Oncology Clinic. Obtained the
number of cervical cancer patients based on sta-
ging; stage IB 8 pts, stage IIA4 pts, stage IIB20
pts,stage IIIA 3 pts, stage IIIB34 pts, stage IVA1 pts
and stage IVB1 pts. The number of the subject of
advanced cervical cancer stage that successfully
screened are 37 people, five subjects do not include
the inclusion criteria; 4 subjects of mild distress
and one subject suffered neuroendocrine type of
cervical cancer. Then 32 subjects fulfilled the inclu-
sion criteria; patients with cervical cancer stage IIB
to IVB with moderate to severe distress and
fulfilled mild to moderate distress criteria. To
determine the subject, it needs to conduct block
randomization; the subject of the treatment group
(n = 16) and controls (n = 16). During the research
in five weeks, there were drop out in both groups.
There were 5 patients from the control group (1
patient passed away, 1 patient back to Java, 1
patient back to Ternate and 2 patients could not
be reached), meanwhile 4 patients from experi-
ment/treatment group (1 patient passed away, 1
patient back to Batam, 1 patient did not want to
continue the research, and 1 patient could not be
reach). Imputation of data needed to be done to
create better and valid statistic analysis and results
in both groups. The flowchart below describes the
research subjects :
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Distribution of cervical cancer patients based on
stage of cervical cancer, as many as 9 (35%) of
people from the Group’s treatment and 6 (40.0%)
those of the control group was at stadium II B. as
much as one (6.7%) people from the control group
are at stage III A while on no treatment group
(0.0%). Then the respondents who are at stage III
B in group treatment as 6 (37.5%) of people and
8 (53.3%) those of the control group. There is no
respondent at stage IVA experiment and control
group.
While respondents who are at stage IV B only 1
(6.3%) people from the experiment group. Score
the thermometer on the experiment group as well
as score in the control group with the range of
lowest value 5 and highest value 9, while the
median value for distress thermometer was good
in both groups. The value of p in the distribution
stage of cancer, the distress thermometer score
and HAM-D17 score entirely > 0.05, means a
control and experiment group are homogenous.
Similarly, the value of P for the variable age,
education, religion, ethnicity and employment in
both research groups is > 0.05, so it can be inferred
that subject demographics research on experiment
and control groups are homogeneous.
Analysis  of  the  Changes  in  Blood  Cortisol
Levels Before and After Supportive Psycho­
therapy
The lives of cancer cells are very supported by
micro-environment around the cancerous tissue.
Cancer and their micro environment able to pro-
duce interleukin pro-inflammation-6 (IL-6) cytoki-
nes. IL-6 cytokines could trigger angiogenesis in
cancer tissue micro environment, the growth and
spreading of cancer cells. IL-6 cytokines could fa-
cilitate the work of IL-1 (interleukin-1) and TNF-
(Tumor Necrotizing Factor-) in the hypothalamus
then it can increase cortisol level in the blood.5
Chronic stress will disrupt along with the effect
of increasing the final HPA T helper type 2 (Th2).
Group T helper has special characteristics secreting
cytokines lymphocytes and IFN- T, which is al-
ready known as prototypes cytokines Th1 and IL-5
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as an indicator high polarized of Th2 cells, so it can
be used to measure the level of each class T helper
Immune Response.11 Th-1 is needed for an effec-
tive antitumor immunity and reportedly is also
connected to increased the disease-free survival
and overall survival.4,11
Then we conduct psychotherapy which aims
to lower cortisol level. Prospective clinical trial
research that evaluates the benefits of the therapy
group supportive-expressive (SEGT/supportive-
expressive group therapy) on the survival of breast
cancer patients who are already metastasize.
Spiegel discovers the existence of benefits (positive
effects) of psychotherapy in reducing growth/
progressiveness for breast cancer who do not have
estrogen receptor, although there’s no benefits on
a group of patients that have estrogen receptors.7
Fawzy et al to evaluate both the initial and long-
term effects of a group who get a structured inter-
vention for six weeks which includes education
about health, increased ability to resolve problems
and distress management techniques. Maligna
Melanoma patients among obtained a clear inter-
vention benefits including reduced significant
psychological distress and immunological changes
when compared to the control group. At further
control six years later of these patients, found an
increase in the risk of recurrence and mortality
occurred more in the control group than the group
of patients with psychosocial interventions have
been performed.
From the results of cortisol in blood the whole
subject of research, the median decrease in cortisol
level obtained group treatment a lot more com-
pared to the control group. There is blood cortisol
level decrease in the treatment group of 39.43
whereas in the control group there was a decrease
of 1.59 (p=0.302). This shows the importance of
supportive psychotherapy in order to lower blood
level of cortisol.
The psychotherapy conducted in this study only
as much as five times. Whereas in previous re-
search, psychotherapy is done as much as 6-10
times and get the resulting improvement in the
mood and the immune system of the patient.12 The
least amount of meetings were given to patients
due to the brevity of time research that resulted in
a decrease in cortisol level in blood was not statis-
tically significant. Another possible cause which
made level of cortisol is not statistically significant
was sampling time. The best time for taking
samples of blood cortisol was in the afternoon-
evening cortisol level when the respondents
returned to basic level of cortisol which only asso-
ciated with the disease.4,5,11 Cortisol sampling
performed when the respondents have arrived at
RSCM after undergoing stressful conditions such as
bogged down in a meaningful way to the Dr. Cipto
Mangunkusumo Hospital.
Analysis  of  Changes  of  the  Distress
Thermometer before and after Supportive
Psychotherapy
From the analysis results of thermometer score,
obtained that the mean distress thermometer prior
to psychotherapy in the treatment group was 6.12
(SB 1.67), whereas in control group was 6.44
(SB 1,32). After giving supportive psychotherapy,
decreasing score happen in treatment group as
average 3.4 and control group as 3.61 (p value >
0.492).
In addition to distress thermometer score, the
study also unravels any problem encountered by
respondents within the last week before measured
the distress thermometer score. Researchers got
the most problem complained that respondents
from the control group were sad and painful
feeling. While in the treatment group, the problems
were obtained in the form of fear, anxiety, grief,
worry, and pain. Almost all respondents revealed
these problems diminished after got psychothe-
rapy.
 
Figure 1. Blood Cortisol Level before and after Suppor-
tive Psychotherapy
before after
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Analysis of  the changes of HAM­D17 Score
before and after Supportive Psychotherapy
After the intervention of psychotherapy in the
treatment group, HAM-D17 score is decreased
with average score 7.53 (SB 3.34). Whereas in the
control group also decreased with the average
score 3.98 (SB 2.85). This difference is statistically
and clinically significant, which means a decrease
in the average HAM-D17 score between the treat-
ment group and the control group has a value of p
= 0.003 (p < 0.005). Based on the analysis results
of summary according to distress level experienced
by 32 respondents obtained 13 people from the
control group experienced mild depression and
three people suffered moderate depression. While
in the treatment group, ten people suffered mild
depression and six people experience moderate
depression.
Table 1. HAM-D17 Score before and after Supportive
Psychotherapy
HAM D17 Group p
Treatment
(n=16)
Control
(n=16)
First 13.63(SB 2.92)
11.75
(SB2.72) 0.070
Second 6.10(SB 2.60)
7.77
(SB 2.96) 0.100
The Delta -7.53(SB 3.34)
-3.98
(SB 2.85) 0.003
From the chart above, HAM-D17 score decreas-
ing in treatment group seem steeper than in the
control group and cortisol delta decreasing is
statistically significant proven. This shows that
supportive psychotherapy in advanced stage cervi-
cal cancer patients experienced mild and moderate
depression disorders are very important. These
results are in accordance with the results from
various studies of supportive psychotherapy that
psychotherapy is effective in lowering depression
symptoms. As shown by the results of two meta-
analyses done by Driessen et al. about the effec-
tiveness of short-term psychodynamic psychothe-
rapy. From 23 1,365 people, found a short-term
dynamic psychotherapy more effective to decrease
symptoms of depression. There was a lot of
changes happened positively after therapy, and the
results of the therapy remained until one year.
When a comparison is done between techniques of
psychotherapy and supportive expressive obtained
there was no significant difference even though
such therapy is given for three or 12 months.13
From research conducted by Cuijpers et al which
compared 7 main types of psychosocial therapy for
patients with mild to moderate depression that are
cognitive behavioral therapy (CBT/Cognitive Be-
havioral Therapy), non supportive directive
therapy, the activation behavior therapy, psycho-
therapy, dynamic problem solving therapy, inter-
personal psychotherapy, and social skills training
concluded that all of the psychosocial therapies
have almost the same effectiveness, except inter-
personal psychotherapy has slightly better effec-
tiveness than the others while non supportive di-
rective psychotherapy has a slightly lower effec-
tiveness compared to others.13 Research by
Goodwin et al about the effectiveness of expressive
supportive psychotherapy in patients who have
experienced metastatic breast cancer concluded
psychotherapy resulted in the improvement of
psychological symptoms, decrease in pain, change
in the form of mood as well as changes in the
perception of pain.11,14
From the results of research by Carlson et al.,
psychosocial therapies that are obtained in the
form of Mindfulness Base Cancer Recovery and
supportive group therapy - expressive given in
breast cancer patients could improve the level of
stress, social support, quality of life and diurnal
cortisol profile. And from research by Nelson et al.,
psychosocial therapy such as Psychosocial Tele-
phone Counseling (PTC) on the cervical cancerFigure 2. The Tendency of Decreasing Score HAM-D 17before and after Supportive Psychotherapy
 
 
before after
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patients could significantly improve the quality of
life and associated with the specific immune
system changes mediated T helper cell group on
cervical cancer patients. And finally, this condition
resulted in improving and increasing life expec-
tancy (survival rate).11,14
Scoring System Using Multiple Variables to
Predict Depression Levels
Variables in the multivariate analysis at this stage
are variable distress thermometer, cortisol, stage
of cancer, marital status and parity. To find a point
of intersection of these variables first performed
bivariate analysis and continued to stage scoring.
Based on the table above, cut-off point curve,
sensitivity, specificity and total score, the best cut
point value for estimating the group of moderate
depression in patients with epithelial cervical
cancer is 32. Probability score of a patient experi-
enced moderate depression can be seen in the
table below.
Table 3. The Probability of a Predictor Score for Depres-
sion Level 
Total score Mild Moderate Probability
 32 2 6 75.0%
< 32 17 7 29.2%
From the analysis above could be inferred the
ROC (Receiving Operating characteristic Curve)
below. Determination of the final scoring model
could predict the level of depression in epithelial
cervical cancer patients as much as 72.47% with
sensitivity 46.15% and specificity 89.47%.
CONCLUSION
The prevalence of distress type depression in
epithelial cervical cancer patients at RSCM as 45%.
Supportive psychotherapy in treating distress
epithelial cervical cancer patients could lower
cortisol level and the score of the distress ther-
mometer. And the supportive psychotherapy had
also proven lowering the score of HAM-D17
(p=0.003). Supportive psychotherapy is very im-
portant in the treatment of cervical cancer patients
who experienced distress type depression.
Hopefully, the "team of Psycho-Oncology" or
"Palliative care and pain management team" in
RSCM would be formed so the cancer patients
could be managed comprehensively.
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